SANKAR NAVANEETHAN to Cause of Death
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Cause of Death.
Connection Strength
2.135
-
Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
Score: 0.493
-
Mortality Outcomes of Patients with Chronic Kidney Disease and Chronic Obstructive Pulmonary Disease. Am J Nephrol. 2016; 43(1):39-46.
Score: 0.417
-
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014). Am J Nephrol. 2018; 48(6):472-481.
Score: 0.126
-
What are the Risk Factors for One-Year Mortality in Older Patients with Chronic Kidney Disease? An Analysis of the Cleveland Clinic CKD Registry. Nephron. 2019; 141(2):98-104.
Score: 0.126
-
High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
Score: 0.121
-
Longitudinal Weight Change During CKD Progression and Its Association With Subsequent Mortality. Am J Kidney Dis. 2018 05; 71(5):657-665.
Score: 0.118
-
Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease. Kidney Int. 2017 11; 92(5):1272-1281.
Score: 0.115
-
Body mass index and causes of death in chronic kidney disease. Kidney Int. 2016 Mar; 89(3):675-82.
Score: 0.103
-
Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD. J Am Soc Nephrol. 2016 Mar; 27(3):877-86.
Score: 0.101
-
Cause-Specific Deaths in Non-Dialysis-Dependent CKD. J Am Soc Nephrol. 2015 Oct; 26(10):2512-20.
Score: 0.099
-
Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
Score: 0.076
-
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 04 29; 4:CD006257.
Score: 0.046
-
Adherence to Healthy Dietary Patterns and Risk of CKD Progression and All-Cause Mortality: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2021 02; 77(2):235-244.
Score: 0.035
-
Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients. J Interv Card Electrophysiol. 2018 Oct; 53(1):123-129.
Score: 0.031
-
Interventions for lowering plasma homocysteine levels in dialysis patients. Cochrane Database Syst Rev. 2016 May 31; (5):CD004683.
Score: 0.027
-
Interventions for lowering plasma homocysteine levels in kidney transplant recipients. Cochrane Database Syst Rev. 2015 May 04; (5):CD007910.
Score: 0.025
-
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2013 Sep 11; (9):CD004289.
Score: 0.022
-
Thyroid hormones for acute kidney injury. Cochrane Database Syst Rev. 2013 Jan 31; (1):CD006740.
Score: 0.021
-
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med. 2012 Aug 21; 157(4):263-75.
Score: 0.020
-
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257.
Score: 0.014